Press release - 16/10/2025 Sleep as the key to understanding ME/CFS The Federal Ministry of Research, Technology and Space (BMFTR) is supporting the “Sleep-Neuro-Path” research network with around 1.6 million euros. Coordinated by the Central Institute of Mental Health (CIMH) in Mannheim, a team of scientists is investigating the role of sleep-related biomarkers in the development of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleep-key-understanding-mecfs
Press release - 30/03/2026 Ulm University funds projects on molecular quantum bits and digital diabetes research Research incubators focus on ideas outside the mainstream Creating scope for innovative projects from various disciplines: That is the aim of the research incubators at Ulm University. The aim is to initiate developments and ideas that could become relevant research areas for the University. In the current call for proposals, the jury has selected two interdisciplinary projects on quantum chemistry and digital, sensor-based diabetes research. https://www.gesundheitsindustrie-bw.de/en/article/press-release/ulm-university-funds-projects-molecular-quantum-bits-and-digital-diabetes-research-research-incubators-focus-ideas-outside-mains
Press release - 16/09/2026 Professor Jakob Nikolas Kather Appointed Hopp Foundation Professor of “Artificial Intelligence in Medicine” and Founding Director of the New Institute for Medical AI (IMAI) in Heidelberg Effective 1 October 2026, Professor Jakob Nikolas Kather will assume the Hopp Foundation Professorship for “Artificial Intelligence in Medicine” at the Heidelberg Faculty of Medicine at Heidelberg University. Associated with the professorship is the establishment of the new Institute for Medical AI (IMAI) at Heidelberg University Hospital, which Professor Kather will lead as its founding director.https://www.gesundheitsindustrie-bw.de/en/article/press-release/professor-jakob-nikolas-kather-appointed-hopp-foundation-professor-artificial-intelligence-medicine-and-founding-director-new-in
New edition - 24/05/2019 Tumour metastasis Cancer is usually not curable when metastases have formed in the body. Metastases are often resistant to drugs that have successfully eliminated the primary tumour. The basic features of the complex process of metastasis are now known, but many details still remain elusive. Intensive research activities are focusing on new therapeutic concepts aimed at developing effective anti-metastatic therapies.https://www.gesundheitsindustrie-bw.de/en/article/dossier/tumour-metastasis
Article - 17/03/2021 Epigenetic switches in bacteria as biosensors The analysis of pathogen biomarkers and biomarkers for the diagnosis of diseases can be crucial for health. However, the detection of pathogens and diseases depends on a sensitive and reliable method that delivers rapid results. Biosensors have such properties. Researchers at the Institute of Biochemistry and Technical Biochemistry (IBTB) at Stuttgart University have constructed an epigenetic circuit composed of plasmids that might make it…https://www.gesundheitsindustrie-bw.de/en/article/news/epigenetic-switches-bacteria-biosensors
Press release - 16/06/2025 Novel laboratory models pave the way for targeted therapies for childhood sarcomas Sarcomas in soft tissue usually occur in young people and are difficult to treat. Due to a lack of laboratory models, the causes of their development are poorly understood. A team of researchers has now succeeded in creating mouse models with a functioning immune system that replicate sarcoma types that remain unstudied. The method opens up new avenues for the targeted development of immunotherapies for children and adolescents with sarcomas.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-laboratory-models-pave-way-targeted-therapies-childhood-sarcomas
Press release - 01/04/2026 Digital Assistance System Designed to Prevent Recurrent Heart Disease Women who have experienced a stroke or heart attack are at a higher risk of mortality than men. Fraunhofer researchers want to improve gender-specific aftercare with a customized assistance system – thus helping to prevent further heart disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-assistance-system-designed-prevent-recurrent-heart-disease
Press release - 07/05/2026 MRI is a better indicator than BMI of when body fat becomes dangerous MRI analysis of fat and muscle distribution in more than 66,000 people provides a more accurate assessment of health risks / Poor muscle quality poses an additional risk / Study provides reference values based on age, sex, and heighthttps://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-better-indicator-bmi-when-body-fat-becomes-dangerous
Enhancing human perception of the imperceptible - 28/08/2025 AI-driven imaging expands possibilities in surgery Doctors frequently experience a restricted view of the surgical field, particularly during endoscopic procedures. A novel technique developed by Prof. Dr. Lena Maier-Hein's team at the DKFZ in Heidelberg integrates spectral imaging with AI-driven data analysis. This innovation facilitates accurate tissue differentiation and delivers real-time insights into organ function.https://www.gesundheitsindustrie-bw.de/en/article/news/ai-driven-imaging-expands-possibilities-surgery
Press release - 24/06/2024 Digital babies created to improve infant healthcare Researchers at University of Galway, the Heidelberg Institute for Theoretical Studies (HITS) Heidelberg University, and Heidelberg University Hospital have created digital babies to better understand infants’ health in their critical first 180 days of life. The international team created computer models that simulate the unique metabolic processes of each baby. The models can help to better understand rare metabolic diseases.https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-babies-created-improve-infant-healthcare
Press release - 26/08/2025 Key mechanism for Alzheimer's disease discovered A molecular mechanism that contributes to the progression of Alzheimer’s disease has been discovered by a research team of Heidelberg University. The team, using an Alzheimer’s mouse model, demonstrated that a neurotoxic protein-protein complex is responsible for nerve cells in the brain dying off and the resulting cognitive decline. This finding opens up new perspectives for the development of effective treatments.https://www.gesundheitsindustrie-bw.de/en/article/press-release/key-mechanism-alzheimers-disease-discovered
Press release - 17/11/2025 How painkillers can contribute to anemia in cancer patients Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-painkillers-can-contribute-anemia-cancer-patients
Baden-Württemberg AI Alliance - 08/04/2025 Achieving widespread use of AI Artificial intelligence presents both opportunities and risks. The Baden-Württemberg AI Alliance is dedicated to fostering collaboration among AI stakeholders to ensure that AI solutions deliver tangible benefits to citizens and businesses across the state. The alliance will also place greater emphasis on advancing AI applications within the healthcare sector.https://www.gesundheitsindustrie-bw.de/en/article/news/achieving-widespread-use-ai
Article - 10/01/2019 Stocktaking and recommendations for action: the BBAW’s fourth gene technology report In the new gene technology report, the interdisciplinary working group of the Berlin-Brandenburg Academy of Sciences (BBAW) takes stock of gene technology developments in Germany during the past few decades, and discusses the societal, legal and ethical challenges associated with these technologies in the future. The report is highly topical due to the controversy surrounding the ruling of the European Court of Justice on CRISPR/Cas9 genome…https://www.gesundheitsindustrie-bw.de/en/article/news/stocktaking-and-recommendations-for-action-the-bbaws-fourth-gene-technology-report
Microfluidics in medical technology - 24/03/2021 Ultra-compact: valves with shape memory actuators Karlsruhe-based company memetis shows that this is possible. Intelligent components for controlling fluids open up huge potential in the medical technology and biotechnology sectors - from vaccine development and cell line analysis to drug research and point-of-care solutions.https://www.gesundheitsindustrie-bw.de/en/article/news/ultra-compact-valves-shape-memory-actuators
Press release - 25/09/2024 How developmental signals can contribute to Genomic Mosaicism Certain developmental signals play a significant role in maintaining our genetic blueprints. They prevent alterations in the genome, known as mosaicism. The underlying biological mechanism helps the DNA to produce an identical copy of itself during cell division using the original genetic blueprint. However, it can also contribute to genomic mosaicism during nerve cell development.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-developmental-signals-can-contribute-genomic-mosaicism
AI-supported image recognition accelerates identification of zebrafish mutants - 16/07/2025 EmbryoNet AI automatically identifies developmental disorders In complex organisms, embryonic development is tightly regulated by intricate signalling pathways. When these pathways are disrupted, they can lead to characteristic developmental defects that are not easy to detect with the naked eye. Developmental biologist Prof. Dr. Patrick Müller from the University of Konstanz has developed EmbryoNet, an AI-powered software tool that uses image analysis to reliably identify such developmental disorders.https://www.gesundheitsindustrie-bw.de/en/article/news/embryonet-ai-automatically-identifies-developmental-disorders
Fluorescence and smartphones instead of laboratories - 11/09/2025 Mobile blood-analysis system for at home medication monitoring For many medications, regular monitoring of drug concentrations in the blood is necessary to ensure efficacy and safety. Until now, this process has been time-consuming and required laboratory personnel and resources. The Heidelberg based start up QuantiLight has developed a mobile device with innovative sensor technology that enables quick, easy measurements at home or in a doctor's surgery.https://www.gesundheitsindustrie-bw.de/en/article/news/mobile-blood-analysis-system-home-medication-monitoring
Diagnostic tool for people with Crohn's disease and ulcerative colitis - 17/06/2025 Chronic inflammatory bowel disease - using an app to sustainably improve everyday life Keeping appointments? Planning everyday life? For people living with chronic inflammatory bowel disease (IBD), sudden and unpredictable flare-ups can severely limit their ability to participate in daily life. The start-up coreway aims to improve the quality of life for individuals affected by IBD by leveraging data-driven insights and contributing to the advancement of personalised medicine.https://www.gesundheitsindustrie-bw.de/en/article/news/chronic-inflammatory-bowel-disease-using-app-sustainably-improve-everyday-life
Review article (new edition) - 08/07/2020 Immunology – at the forefront of medical progress Immunology is constantly changing with the emergence of new technologies and areas of application, and has branched out in many directions. Immunological approaches are central to everything – be it the development of innovative active substances and vaccinations against cancer, the search for new therapies against neurodegenerative diseases or autoimmune diseases, or combatting well-known infectious diseases or new virus epidemics.https://www.gesundheitsindustrie-bw.de/en/article/dossier/immunology-forefront-medical-progress